On October 20, 2023, Ildong Pharmaceutical Co., Ltd. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15,280 KRW | +1.39% | +1.73% | -15.86% |
2023 | Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea | MT |
2023 | Il Dong Pharmaceutical Introduces New R&D Unit Yunovia | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.86% | 310M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- A249420 Stock
- News Ildong Pharmaceutical Co., Ltd.
- Ildong Pharmaceutical Co., Ltd. announced that it has received KRW 30 billion in funding